Health-Related Quality-of-Life and Quality-Days Incrementally Gained in Symptomatic Nonerosive GERD Patients Treated with Lansoprazole or Ranitidine
Authors:
- 1 November 2001
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 46 (11) , 2416-2423
Abstract
Eight-hundred forty-nine patients with symptomatic nonerosive GERD from two clinical trials of lansoprazole 15 mg daily (LAN 15) and lansoprazole 30 mg daily (LAN 30) vs ranitidine 150 mg twice a day...Keywords
This publication has 21 references indexed in Scilit:
- Development of a Health-Related Quality-of-Life Questionnaire for Individuals with Gastroesophageal Reflux Disease (A Validation Study)Digestive Diseases and Sciences, 1999
- A comparison of two approaches for assessing patient importance weights to conduct an Extended Q-TWiST analysisQuality of Life Research, 1999
- Use of the Short Form-36 to detect the influence of upper gastrointestinal disease on self-reported health status.1998
- Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisaprideAlimentary Pharmacology & Therapeutics, 1997
- Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, MinnesotaGastroenterology, 1997
- The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.1996
- Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology.1995
- Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.1995
- Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.1993
- Older Patients?? Health Status and Satisfaction With Medical Care in an HMO PopulationMedical Care, 1990